Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
Koon Jiew Chua, Hua Ling, In Young Hwang, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 9, Iss. 9, pp. 5123-5135
Open Access | Times Cited: 21

Showing 21 citing articles:

Intestinal Delivery of Probiotics: Materials, Strategies, and Applications
Chengcheng Li, Zi‐Xi Wang, Huining Xiao, et al.
Advanced Materials (2024) Vol. 36, Iss. 32
Closed Access | Times Cited: 25
Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
Jiaoying Lu, Xinyuan Shen, Hongjun Li, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 17
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery
Maoyi Li, Nanhui Liu, Jiafei Zhu, et al.
Biomaterials (2024) Vol. 309, pp. 122584-122584
Closed Access | Times Cited: 17
Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis
Ni Guo, Lu‐lu Lv
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 31
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Spase Stojanov, Aleš Berlec
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions
Ashutosh Tiwari, Dyah Ika Krisnawati, Erna Susilowati, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 50, pp. 27679-27700
Open Access | Times Cited: 5
Anti-tumor activity of an αPD-L1-PE38 immunotoxin delivered by engineered Nissle 1917
Xinrui Li, Yangui Wang, Yanqing Wang, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139537-139537
Closed Access
Engineered Probiotic-Based Biomaterials for Inflammatory Bowel Disease Treatment
Guangze Sang, Bo Wang, Yujie Xie, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3289-3315
Open Access
Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities
Hitesh P Gelli, Ruben Vazquez-Uribe, Stephen T. Buckley, et al.
Advanced Drug Delivery Reviews (2025), pp. 115603-115603
Closed Access
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Nabendu Debnath, Pooja Yadav, Praveen Kumar Mehta, et al.
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 1, pp. 100-117
Closed Access | Times Cited: 8
Lipid-Encapsulated Engineered Bacterial Living Materials Inhibit Cyclooxygenase II to Enhance Doxorubicin Toxicity
Ning Jiang, Wanqing Ding, Xiaojuan Zhu, et al.
BioDesign Research (2024) Vol. 6
Open Access | Times Cited: 3
Genetically engineered bacteria as inflammatory bowel disease therapeutics
Zhen‐Ping Zou, Xiao-Peng Zhang, Qian Zhang, et al.
Engineering Microbiology (2024) Vol. 4, Iss. 4, pp. 100167-100167
Open Access | Times Cited: 2
Engineering bacterial theranostics: from logic gates to in vivo applications
Angus Armstrong, Mark Isalan
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease
Yuewen Huang, Peng Shan, Rong Zeng, et al.
Microbiological Research (2024) Vol. 289, pp. 127928-127928
Closed Access | Times Cited: 2
Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions
Rajkamal Srivastava, Cammie F. Lesser
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Advancements in Microbial Cell Engineering for Benzylisoquinoline Alkaloid Production
Liyan Cao, Desmond Teo, Yuyang Wang, et al.
ACS Synthetic Biology (2024)
Closed Access | Times Cited: 1
Engineering live bacterial therapeutics to treat human diseases
In Young Hwang
Current Opinion in Systems Biology (2023) Vol. 37, pp. 100492-100492
Closed Access | Times Cited: 2
Probiotics for Inflammatory Bowel Disease; A Deep Dive into Their Impact on Disease Course and Associated Health Risks
Wassan Nori, Methaq Mueen Al-kaabi, Nabeeha Najatee Akram, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 30, pp. 4807-4825
Closed Access
A Review on Microengineering of Epithelial Barriers for Biomedical and Pharmaceutical Research
Ruchira Chakraborty, Pragyan Ray, Subhasish Barik, et al.
ACS Applied Bio Materials (2024)
Closed Access
Research and application of intelligent diagnosis and treatment engineering bacteria
Na Zhao, Junwei Chen, Jiuyun Shi, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
ACS Biomaterials Science and Engineering Special Issue Editorial: Design and Evaluation of Engineered Probiotics
Michael S. Goodson
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 9, pp. 5098-5100
Closed Access
Page 1

Scroll to top